• A Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia France Germany Greece +6

  • Continuing vs Stopping Acetylsalicylic Acid in Elderly Patients with Chronic Coronary Syndrome (Secondary Prevention): A Randomized Trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway

  • Effect of methohexital, propofol, and etomidate on electroconvulsive therapy outcomes in patients with severe depression

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland

  • Effect of Methylphenidate versus Placebo on Attachment‑Related Learning in Children with Attention‑Deficit/Hyperactivity Disorder (ADHD)

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium

  • Phase II study of inotuzumab ozogamicin to prevent relapse in adult high‑risk acute lymphoblastic leukaemia patients after allogeneic stem cell transplant

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Safety and efficacy of locally administered APAC, heparin sodium and sodium chloride to promote arteriovenous fistula maturation in patients with end‑stage kidney disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland Spain Sweden

  • Efficacy of fluoxetine added to standard anti‑seizure therapy in children aged 8 years and older with drug‑resistant complex and rare epilepsy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • A Randomized Trial of lu af28996 dh1 to Reduce Motor Fluctuations in Adults with Parkinson’s Disease

    Not yet recruiting

    2 1
    Czechia France Germany Italy Poland Spain +1

  • Efficacy and safety of remibrutinib (LOU064) in adult patients with papulopustular rosacea: a randomized, double‑blind, placebo‑controlled Phase 2 trial

    Not yet recruiting

    2 1
    Investigated Drugs:
    Bulgaria France Germany Italy Spain

  • A study of NNC0638-0355 to evaluate safety, tolerability and weight loss with multiple doses in adults with obesity or overweight

    Not yet recruiting

    2 1
    Investigated Diseases:
    The Netherlands

powered by